There’s always debate about stem cells and regenerative medicine, right? There are very strong opinions in our field. Here is a list of 10 current, provocative questions. I have my own ideas about the answers to these. Weigh in with comments with your answers. I’m going to do a follow up post with some discussion of the […]
10 provocative stem cell questions: what are your answers? Read More »
Keep your hands off of my cells! At least, that is what many are telling the FDA regarding stem cells. The FDA issued four draft guidances related to stem cells in the past year or so, held two public stem cell meetings, and now must decide what it is going to do with an out
4,000+ comments on FDA stem cell guidances, mostly clones of “My cells are my cells” Read More »
The FDA is holding a 2-day stem cell meeting starting tomorrow and it promises to be a really big deal. What’s the scoop on this meeting and the attendees? Who is likely to say what? If the deregulatory proponents get their way, could we have stem cell clinics like Starbucks popping up in even more neighborhoods? I have
Guide to September 12-13 FDA Stem Cell Meeting Read More »
That much-anticipated public FDA stem cell meeting that was postponed from April will now take place in September and will have a much larger array of diverse speakers. Many more voices at an FDA stem cell meeting are collectively a good thing, but delay is not. The large and growing U.S. stem cell clinic industry makes
September FDA stem cell meeting looks to be big debate Read More »
A new paper was recently published on CRISPR of human embryos for genetic modification. I’ve got to read this publication more carefully, but here’s a quick initial take on this human CRISPR 2.0 study. The paper is Kang, et al. and is entitled “Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing”.
New Paper on CRISPR of Human Embryos Highlights Serious Tech Problems Read More »
ISSCR Chat By Michael Cea Jeanne Loring of the Scripps Research Institute in La Jolla, California kindly sat down with me at the ISSCR annual meeting for a broad discussion of her history, views on the field and developments in the science. I found Jeanne a refreshing character, as I did a number of others I was
Michael Cea ISSCR chat with Jeanne Loring on stem cell field Read More »
Rumors have been flying for months that researchers in China and possibly elsewhere were shopping papers around at high-profile journals that reported gene editing and genetic modification of human embryos. Update: apparently this paper (HT to @JohnBorghi) was only reviewed for 2 days (see image at bottom of post), raising major concerns about the depth of
Researchers in China make genetically modified human embryos Read More »
NBC News did a big on-line story and even a NBC Nightly News Segment on dubious stem cell therapies on Friday. Normally a national news story on the problem of the mushrooming stem cell clinics selling unapproved “treatments” would be a positive development, but this otherwise very nicely done story might have a major error that could confuse millions
Did NBC News Err On Key Part of Their Stem Cell Report? Read More »
I’ve really enjoyed day 2 of ISSCR 2014. So far this day has already packed in a slew of great talks both in the lecture halls and outside one-on-one with old friends and new ones. How great is that? I’ll focus on just a few highlights to keep it concise. Dubious stem cell clinics and
ISSCR 2014 Day 2: Navigating Balanced Stem Cell Path to Clinic Read More »
The Cell Surgical Network is a for-profit network of clinics offering various stem cell-related interventions, which began with the California Stem Cell Treatment Center. I have interviewed Drs. Elliot Lander and Mark Berman of the Network in past (Part 1, Part 2) and I raised some concerns about the network in a follow up Part 3 post,
Update on Cell Surgical Network IRB Status Read More »